1'-acetoxychavicol acetate has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, BB; Chen, J; Lai, L; Liu, M; Pang, X; Qu, W; Wu, Y; Yi, Z; Zhang, J; Zhang, L | 1 |
1 other study(ies) available for 1'-acetoxychavicol acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Benzyl Alcohols; Blotting, Western; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Focal Adhesion Kinase 1; Humans; Male; Mice; Neovascularization, Pathologic; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; RNA, Messenger; Signal Transduction; src-Family Kinases; Umbilical Veins; Vascular Endothelial Growth Factor A; Xanthine Oxidase; Xenograft Model Antitumor Assays | 2011 |